S100B in schizophrenic psychosis

International Review of Neurobiology

Volumn 59, Issue , 2004, Pages 445-470

  Rothermundt, Matthias ^a   Ponath, Gerald ^a   Arolt, Volker ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT; SEROTONIN;

ANIMAL; BRAIN CORTEX; BRAIN INJURY; CELL CULTURE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; GLIA; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; IN VITRO STUDY; METABOLISM; NERVE CELL; PATHOLOGY; REVIEW; SCHIZOPHRENIA;

ANIMALS; BRAIN INJURIES; CELLS, CULTURED; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; HUMANS; NERVE GROWTH FACTORS; NEUROGLIA; NEUROIMMUNOMODULATION; NEURONS; S100 PROTEINS; SCHIZOPHRENIA; SEROTONIN;

EID: 1942514786     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(04)59017-7     Document Type: Article

References (156)

1. Adami, C., Sorci, G., Blasi, E., Agneletti, A. L., Bistoni, F., and Donato, R. (2001). S100B Expression in and effects on microglia. Glia 33, 131-142.
2. 1A-rcceptor agonist, Bay × 3702. Brain Res. 858, 121-128.
3. Albert, K. A., Wu, W. C., Nairn, A. C., and Greengard, P. (1984). Inhibition by calmodulin of calcium/phospholipid-dependent protein phosphorylation. Proc. Natl. Acad. Sci. USA 81, 3622-3625.
4. Alexanian, A. R., and Bamburg, J. R. (1999). Neuronal survival activity of S100 betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB. FASEB J. 13, 1611-1620.
5. Allore, R., O'Hanlon, D., Price, R. E., Neilson, K., Willard, H. F., Cox, D. R., Marks, A., and Dunn, R. J. (1988). Gene encoding the beta subunit of S100 protein is on chromosome 21: Implications for Down syndrome. Science 239, 1311-1313.
6. Arnold, S. E. (1999). Neurodevelopmental abnormalities in schizophrenia: Insights from neuropathology: Dev. Psychopathol. 11, 439-456.
7. 1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain. Brain Res. 677, 181-192.
8. Barger, S. W., and Van Eldik, L. J. (1992). S100β stimulates calcium fluxes in glial and neuronal cells. J. Biol. Chem. 267, 9689-9694.
9. Barger, S. W., Van Eldik, L. J., and Mattson, M. P. (1995). S100β protects hippocampal neurons from damage induced by glucose deprivation. Brain Res. 677, 167-170.
10. Bartzokis, G. (2002). Schizophrenia: Breakdown in the well-regulated lifelong process of brain development and maturation. Neuropsychopharmacology 27, 672-683.
11. 2+ calmodulin-dependent protein kinase II. J. Biol. Chem. 263, 5876-5883.
12. Baudier, J., Delphin, C., Grunwald, D., Khochbin, S., and Lawrence, J. J. (1992). Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Biochemisty 89, 11627-11631.
13. Baudier, J., Mochly-Rosen, D., Newton, A., Lee, S. H., Koshland, D. E., Jr., and Cole, R. D. (1987). Comparison of S100b protein with calmodulin: Interactions with melittin and microtubule-associated tau proteins and inhibition of phosphorylation of tau proteins by protein kinase C. Biochemistry 26, 2886-2893.
14. Beaudeux, J. L., Dequen, L., and Foglietti, M. J. (1999). La protéine S-100β: Un nouveau marquer biologique de pathologie cérébrale. Ann. Biol. Clin. 57, 261-272.
15. Bhattacharyya, A., Oppenheim, R. W., Prevette, D., Moore, B. W., Brackenbury, R., and Ratner, N. (1992). S100 is present in developing chicken neurons and schwann cells and promotes motor neuron survival in vivo. J. Neurobiol. 23, 451-466.
16. 2+-dependent manner. J. Biol. Chem. 268, 12669-12674.
17. Bianchi, R., Verzini, M., Garbuglia, M., Giambando, I., and Donato, R. (1994). Mechanism of S100 protein-dependent inhibition of glial fibrillary acidic protein (GFAP) polymerization. Biochim. Biophys. Acta 1223, 354-360.
18. Brenneman, D. E., Schultzberg, M., Bartfai, T., and Gozes, I. (1992). Cytokine regulation of neuronal survival. J. Neurochem. 58, 454-460.
19. Brewton, L. S., Haddad, L., and Azmitia, E. C. (2001). Colchicine-induced cytoskeletal collapse and apoptosis in N-18 neuroblastoma cultures is rapidly reversed by applied S-100β. Brain Res. 912, 9-16.
20. Davies, D. L., Niesmann, I. R., Boop, F. A., and Phelan, K. D. (2000). Heterogeneity of astroglia cultured from adult human temporal lobe. Int. J. Dev. Neurosci. 18, 151-160.
21. DeLisi, L. E. (1999). Defining the course of brain structural change and plasticity in schizophrenia. Psychiat. Res. Neuroimag. 92, 1-9.
22. Donato, R. (1985). Calcium-sensitivity of brain microtubule proteins in the presence of S-100 proteins. Cell Calcium 6, 343-361.
23. Donato, R. (1988). Calcium-independent, pH-regulated effects of S-100 proteins on assembly-disassembly of brain microtubule protein in vitro. J. Biol. Chem. 263, 106-110.
24. Donato, R. (1991). Perspectives in S-100 protein biology. Cell Calcium 12, 713-726.
25. Donato, R. (2001). S100: A multigenic family of calcium-modulated proteins of the EF-band type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33, 637-668.
26. Drohat, A. C., Amburgey, J. C., Abildgaard, F., Starich, M. R., Baldisseri, D., and Weber, D. J. (1996). Solution structure of rat apo-S100B(beta beta) as determined by NMR spectroscopy. Biochemistry 35, 11577-11588.
27. Drohat, A. C., Baldisseri, D. M., Rustandi, R. R., and Weber, D. J. (1998). Solution structure of calcium-bound rat S100B (beta beta) as determined by nuclear magnetic resonance spectroscopy. Biochemistry 37, 2729-2740.
28. Duda, T., Goraczniak, R. M., and Sharma, R. K. (1996). Molecular characterization of S100A1-S100B protein in retina and its activation mechanism of bovine photoreceptor guanylate cyclase. Biochemistry 35, 6263-6266.
29. Elvevag, B., and Goldberg, T. E. (2000). Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 14, 1-21.
30. Eriksen, J. L., Gillespie, R. A., and Druse, M. J. (2000). Effects of in utero ethanol exposure and maternal treatment with a 5-HT1A agonist on S100B-containing glial cells. Dev. Brain Res. 121, 133-143.
31. Friend, W. C., Clapoff, S., Landry, C., Becker, L. E., O'Hanlon, D., Allore, R. J., Brown, I. R., Marks, A., Roder, J., and Dunn, R. J. (1992). Cell-specific expression of high levels in human S100β in transgenic mouse brain is dependent of gene dosage. J. Neurosci. 12, 4337-4346.
32. Fujii, T., Oomatsuzawa, A., Kuzumaki, N., and Kondo, Y. (1994). Calcium-dependent regulation of smooth muscle calponin by S100. J. Biochem. 116, 121-127.
33. 2+-binding protein (S100)-dependent apoptosis in rat phaeochromocytoma cells. Exp. Physiol. 85, 243-253.
34. Garbuglia, M., Verzini, M., Giambanco, I., Spreca, A., and Donato, R. (1996). Effects of calcium-binding proteins (S-100a(o)S-100a, S-100b) on desmin assembly in vitro. FASEB J. 10, 317-324.
35. Garbuglia, M., Verzini, M., Hofmann, A., Huber, R., and Donato, R. (2000). S100A1 and S100B interactions with annexins. Biochim. Biophys. Acta 20, 192-206.
36. Gattaz, W. F., Lara, D. R., Elkis, H., Portel, L. V., Goncalves, C. A., Tort, A. B., Henna, J., and Souza, D. O. (2000). Decreased S100-beta protein in schizophrenia: Preliminary evidence. Schizophr. Res. 43, 91-95.
37. Gerlai, R., Friend, W., Becker, L., O'Hanlon, D., Marks, A., and Roder, J. (1993). Female transgenic mice carrying multiple copies of the human gene for S100β are hyperactive. Behav. Brain Res. 55, 51-59.
38. Gerlai, R., Marks, A., and Roder, J. (1994). T-maze spontaneous alternation rate is decreased in S100β transgenic mice. Behav. Neurosci. 108, 100-106.
39. Gerlai, G., and Roder, J. (1993). Female specific hyperactivity in S100β transgenic mice does not habituate in open-field. Behav. Brain Res. 59, 119-124.
40. Gerlai, R., and Roder, J. (1995). Abnormal exploratory behavior in transgenic mice carrying multiple copies of the human gene for S100β. J. Psychiat. Neurosci. 20, 105-112.
41. Gerlai, R., and Roder, J. (1996). Spatial and nonspatial learning in mice: Effects of S100β overexpression and age. Neurobiol. Learn. Mem. 66, 143-154.
42. Gerlai, R., Wojtowicz, J. M., Marks, A., and Roder, J. (1995). Overexpression of a calcium-binding protein, S100β, in astrocytes alters synaptic plasticity and impairs spatial learning in transgenic mice. Learn. Mem. 2, 26-39.
43. Glantz, L. A., and Lewis, D. A. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiat. 57, 65-73.
44. Goncalves, D. S., Lenz, G., Karl, J., Goncalves, A., and Rodnight, R. (2000). Extracellular S100B protein modulates ERK in astrocyte cultures. Glial Cells 11, 807-809.
45. Griffin, W. S. T., Sheng, J. G., and Mrak, R. E. (1998). Senescence-accelerated overexpression of S100β in brain of SAMP6 mice. Neurobiol. Aging 19, 71-76.
46. Gromow, L. A., Syrovatskaya, L. P., and Ovinova, G. V. (1992). Functional role of the neurospecific S-100 protein in the processes of memory. Neurosci. Behev. Physiol. 22, 25-29.
47. Gur, R. E., Cowell, P., Turetsky, B. I., Gallacher, F., Cannon, T., Bilker, W., and Gur, R. C. (1998). A follow-up magnetic resonance imaging study of schizophrenia. Arch. Gen. Psychiat. 55, 145-152.
48. Hardemark, H. G., Ericsson, N., Kotwica, Z., Rundström, G., Mendel-Hartwig, I. B., Olsson, Y., Pahlman, S., and Persson, L. (1989). S-100 protein and neuron-specific enolase in CSF after experimental traumatic of focal ischemic brain damage. J. Neurosurg. 71, 727-731.
49. Haring, J. H., Hagan, A., Olson, J., and Rodgers, B. (1993). Hippocampal serotonin levels influence the expression of S100β detected by immunocytochemistry. Brain Res. 631, 119-123.
50. Harrison, P. J. (1999). The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain 122, 593-624.
51. Harrison, P. J., and Eastwood, S. L. (2001). Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 11, 508-519.
52. 2+/S100 regulation of giant protein kinases. Nature 380, 636-639.
53. Heinrichs, R. W., and Zakzanis, K. K. (1998). Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropychology 12, 426-445.
54. 2+-binding S100 proteins in the central nervous system. Neurochem. Res. 24, 1097-1100.
55. 2+-binding protein family. Biometals 11, 383-397.
56. Hinkle, D. A., Baldwin, S. A., Scheff, S. W., and Wise, P. M. (1997). GFAP and S100β expression in the cortex and hippocampus in response to mild cortical contusion. J. Neurotrauma 14, 729-738.
57. Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., and Nitecki, D. (1995). The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J. Biol. Chem. 270, 25752-25761.
58. Hu, J., Castets, F., Guevara, J. L., and Van Eldik, L. J. (1996). S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271, 2543-2547.
59. Hu, J., Ferreira, A., and Van Eldik, L. J. (1997). S100 beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69, 2294-2301.
60. Huang, J., Strafaci, J. A., and Azmitia, E. C. (1997). 5-HT 1A receptor agonist reverses adrenalectomy-induced loss auf granule neuronal morphology in the rat dentate gyrus. Neurochem. Res. 22, 1329-1337.
61. Huttunen, H. J., Kuja-Panula, J., Sorci, G., Agneletti, A. L., Donata, R., and Rauvala, H. (2000). Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275, 40096-40105.
62. Isobe, T., and Okuyama, T. (1978). The amino-acid sequence of S-100 protein (PAP I-b protein) and its relation to the calcium-binding proteins. Eur. J. Biochem. 89, 379-388.
63. Ivanenkov, V. V., Jamieson, G. A., Jr., Gruenstein, E., and Dimlich, R. V. (1995). Characterization of S-100b binding epitopes: Identification of a novel target, the actin capping protein, CapZ. J. Biol. Chem. 270, 14651-14658.
64. Jankovic, B. D., Jakulic, S., and Horvat, J. (1980). Schizophrenia and other psychiatric diseases: Evidence for neurotissue hypersensitivity. Clin. Exp. Immunol. 40, 515-522.
65. Jankovic, B. D., Jakulic, S., and Horvat, J. (1982). Delayed skin hypersensitivity reactions to human brain S-100 protein in psychiatric patients. Biol. Psychiat. 17, 687-697.
66. Karpiak, S. E., Serokosz, M., and Rapport, M. M. (1976). Effects of antisera to S-100 protein and to synaptic membrane fraction on maze performance and EEG. Brain Res. 102, 313-321.
67. Karson, C. N., Mrak, R. E., Schluterman, K. O., Sturner, W. Q., Sheng, J. G., and Griffin, W. S. T. (1999). Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: A possible neurochemical basis for "hypofrontality." Mol. Psychiat. 4, 39-45.
68. Kato, K., Suzuki, F., Morishita, R., Asano, T., and Sato, T. (1990). Selective increase in S-100 beta protein by aging in rat cerebral cortex. J. Neurochem. 54, 1269-1274.
69. Kilby, P. M., Van Eldik, L. J., and Roberts, G. C. (1996). The solution structure of the bovine S100B protein dimer in the calcium-free state. Structure 4, 1041-1052.
70. Kilby, P. M., Van Eldik, L. J., and Roberts, G. C. (1997). Idendfication of the binding site on S100B protein for the actin capping protein CapZ. Protein Sci. 6, 2494-2503.
71. Koppal, T., Lam, A. G. M., Guo, L., and Van Eldik, L. J. (2001). S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia. Neurochem. Int. 39, 401-407.
72. Kung, L., Conley, R., Chute, D. J., Smialik, J., and Roberts, R. C. (1998). Synaptic changes in the striatum of schizophrenic cases: A controlled postmortem ultrastructural study. Synapse 28, 125-139.
73. Landar, A., Caddell, G., Chessher, J., and Zimmer, D. B. (1996). Identification of an S100A/S100B target protein: phosphoglucomutase. Cell Calcium 20, 279-285.
74. Lara, D. R., Gama, C. S., Belmonte-de-Abreu, P., Portela, L. V. C., Goncalves, C. A., Fonseca, M., Hauck, S., and Souza, D. O. (2001). Increased serum S100B protein in schizophrenia: A study in medication-free patients. J. Psychiat. Res. 35, 11-14.
75. Lewis, D., and Teyler, T. J. (1986). Anti-S-100 serum blocks long-term potentiation in the hippocampal slice. Brain Res. 383, 159-164.
76. Li, Y., Barger, S. W., Liu, L., Mrak, R. E., and Griffin, W. S. T. (2000). S100β induction of the proinflammatory cytokine interleukin-6 in neurons. J. Neurochem. 74, 143-150.
77. Li, Y., Wang, J., Sheng, J. G., Liu, L., Barger, S. W., Jones, R. A., Van Eldik, L. J., Mrak, R. E., and Griffin, W. S. T. (1998). S100β increases levels of β-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J. Neurochem. 71, 1421-1428.
78. Lieberman, J. A., Sheitman, B. B., and Kinon, B. J. (1997). Neurochemical sensitization in the pathophysiology of schizophrenia: Deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 17, 205-229.
79. Lin, J., Blake, M., Tang, C., Zimmer, D., Rustandi, R. R., Weber, D. J., and Carrier, F. (2001). Inhibition of p53 transcriptional activity bei the S100B calcium binding protein. J. Biol. Chem. 276, 35037-35041.
80. Lin, L. H., Van Eldik, L. J., Osheroff, N., and Norden, J. J. (1994). Inhibition of protein kinase C- and casein kinase II-mediated phosphorylation of GAP-43 by S100 beta. Mol. Brain Res. 25, 297-304.
81. Manev, H., and Manev, R. (2001). S100B: An old neurotrophic factor with putative new roles in psychiatric illnesses. J. Psychiat. Res. 35, 347-348.
82. Marenco, S., and Weinberger, D. R. (2000). The neurodevelopmental hypothesis of schizophrenia: Following a trail of evidence from cradle to grave. Dev. Psychopathol. 12, 501-527.
83. Margulis, A., Pozdnyakov, N., and Sitaramayya, A. (1996). Activation of bovine photoreceptor guanylate cyclase by S100 proteins. Biochem. Biophys. Res. Commun. 218, 243-247.
84. Mariggio, M. A., Fulle, S., Calissano, P., Nicoletti, I., and Fano, G. (1994). The brain protein S-100b induces apoptosis in PG12 cells. Neuroscience 60, 29-35.
85. Matsumura, H., Shiba, T., Onoue, T., Harada, S., and Kai, Y. (1998). A novel mode of target recognition suggested by the 2.0 A structure of hole S100B from bovine brain. Structure 6, 233-241.
86. Mazer, C., Muneyyirci, J., Taheny, K., Raio, N., Borella, A., and Witaker-Azmitia, P. (1997). Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: A possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 760, 68-73.
87. McAdory, B. S., Van Eldik, L. J., and Norden, J. J. (1998). S100B, a neurotropic protein that modulates neuronal protein phosphorylation, is upregulated during lesion-induced collateral sprouting and reactive synaptogenesis. Brain Res. 813, 211-217.
88. McGlashan, T. H., and Hoffman, R. E. (2000). Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch. Gen. Psychiat. 57, 637-648.
89. Mello e Souza, T., Rohden, A., Meinhardt, M., Goncalves, C. A., and Quillfeldt, J. A. (2000). S100B infusion into the rat hippocampus facilitates memory for the inhibitory avoidance task but not for the open-field habituation. Physiol. Behav. 71, 29-33.
90. Millward, T. A., Heizmann, C. W., Schärfer, B. W., and Hemmings, B. A. (1998). Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 17, 5913-5922.
91. Mimics, K., Middleton, F. A., Lewis, D. A., and Levitt, P. (2001). Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse. Trends Neurosci. 24, 479-486.
92. Moore, B. W. (1965). A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 19, 739-744.
93. 1A agonist, S100b, and corticosteroid receptor agonists. Synapse 23, 1-9.
94. Nishikawa, T., Lee, I. S. M., Shiraishi, N., Ishikawa, T., Ohta, Y., and Nishikimi, M. (1997). Identification of S100b protein as copper-binding protein and its suppression of copper-induced cell damage. J. Biol. Chem. 272, 23037-23041.
95. Nishiyama, H., Knopfel, T., Endo, S., and Itohara, S. (2002a). Glial protein S100B modulates long-term neuronal synaptic plasticity. Proc. Natl. Acad. Sci. USA 99, 4037-4042.
96. Nishiyama, H., Takemura, M., Takeda, T., and Itohara, S. (2002b). Normal development of serotonergic neurons in mice lacking S100B. Neurosci. Lett. 321, 49-52.
97. Niu, H., Hinkle, D. A., and Wise, P. W. (1997). Dexamethasone regulates basic fibroblast growth factor, nerve growth factor and S100β expression in cultured hippocampal astrocytes. Mol. Brain. Res. 51, 97-105.
98. O'Dowd, B. S., Zhao, W. Q., Ng, K. M., and Robinson, S. R. (1997). Chicks injected with antisera to either S-100α or S-100β protein develop amnesia for a passive avoidance task. Neurobiol. Learn. Mem. 67, 197-206.
99. Ozaki, M. (2001). Neuregulins and the shaping of synapses. Neuroscientist 7, 146-154.
100. Pearlson, G. D., and Marsh, L. (1999). Structural brain imaging in schizophrenia: A selective review. Biol. Psychiat. 46, 627-649.
101. Pena, L. A., Brecher, C. W., and Marshak, D. R. (1995). β-Amyloid regulates gene expression of glial trophic substance S100β in C6 glioma and primary astrocyte cultures. Mol. Brain. Res. 34, 118-126.
102. Petrova, T., Hu, J., and Van Eldik, L. J. (2000). Modulation of glial activation by astrocyte-derived protein S100B: Differential responses of astrocyte and microglial cultures. Brain Res. 853, 74-80.
103. Polyakov, A. A., Huber, P. A., Marston, S. B., and Gussev, N. B. (1998). Interaction of isoforms of S100 protein with smooth muscle caldesmon. FEBS Lett. 422, 235-239.
104. Powers, R. E. (1999). The neuropathology of schizophrenia. J. Neuropathol. Exp. Neurol. 58, 679-690.
105. Pozdnyakov, N., Goraczniak, R., Margulis, A., Duda, T., Sharma, R. K., Yoshida, A., and Sitaramayya, A. (1997). Structural and functional characterization of retinal calcium-dependent guanylate cyclase activator protein (CD-GCAP): identity with S100β protein. Biochemistry 36, 14159-14166.
106. Pozdnyakov, N., Margulis, A., and Sitaramayya, A. (1998). Identification of effector binding sites on S100β: Studies with guanylate cyclase and p80, a retinal phosphoprotein. Biochemistry 37, 10701-10708.
107. Pritchard, K., and Marston, S. B. (1991). Ca(2+)-dependent regulation of vascular smooth-muscle caldesmon by S100 and related smooth-muscle proteins. Biochem. J. 277, 819-824.
108. Rambotti, M. G., Giambanco, I., Spreca, A., and Donato, R. (1999). S100B and S100A1 proteins in bovine retina: Their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracystochemistry. Neuroscience 92, 1089-1101.
109. Reeves, R. H., Yao, J., Crowley, R., Buck, S., Zhang, X., Yarowsky, P., Gearhart, J. D., and Hilt, D. C. (1994). Astrocytosis and axonal proliferation in the hippocampus of S100b transgenic mice. Proc. Natl. Acad. Sci. USA 91, 5359-5363.
110. Reiber, H. (2001). Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chim. Acta 310, 173-186.
111. Reston, J. T., Hu, X. L., Macina, R. A., Spais, C., and Riethman, H. C. (1995). Structure of the terminal 300 kb of DANN from human chromosome 21q. Genomics 26, 31-38.
112. Roder, J. K., Roder, J. C., and Gerlai, R. (1996a). Conspecific exploration in the T-maze: Abnormalities in S100β transgenic mice. Physiol. Behav. 60, 31-36.
113. Roder, J. K., Roder, J. C., and Gerlai, R. (1996b). Memory and the effect of cold shock in the water maze in S100β transgenic mice. Physiol. Behav. 60, 611-615.
114. Rothermundt, M., Arolt, V., and Bayer, T. A. (2001a). Review of immunological and immunopathological findings in schizophrenia. Brain Behav. Immun. 15, 319-339.
115. Rothermundt, M., Missler, U., Arolt, V., Peters, M., Leadbeater, J., Wiesmann, M., Rudolf, S., Wandinger, K. P., and Kirchner, H. (2001b). Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol. Psychiat. 6, 445-449.
116. Rothermundt, M., Peters, M., Prehn, J. H. M., and Arolt, V. (2003). S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 60, 614-632.
117. Rothermundt, M., Ponath, G., Glaser, T., Hetzel, G., and Arolt, V. (2004). S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia. Neuropsychopharmacology, electronic publication, 2004, NPP01080403371.
118. Rothoerl, R. D., Brawanski, A., and Wortgen, C. (2000a). S-100B protein serum levels after controlled cortical impact injury in the rat. Acta Neurochir. (Wien) 142, 199-203.
119. Rustandi, R. R., Drohat, A. C., Caldisseri, D. M., Wilder, P. T., and Weber, D. J. (1998). The Ca(2+)-dependent interaction of S100B (beta beta) with a peptide derived from p53. Biochemistry 37, 1951-1960.
120. Schäfer, B. W., and Heizmann, C. W. (1996). The S100 family of EF-hand calcium-binding proteins: Functions and pathology. Trends Biochem. Sci. 21, 134-140.
121. Schroeter, M. L., Abdul-Khaliq, H., Fruhauf, S., Hohne, R., Schick, G., Diefenbacher, A., and Blasig, I. E. (2003). Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia. Schizophr. Res. 62, 231-236.
122. Scotto, C., Deloulme, J. C., Rousseau, D., Chambaz, E., and Baudier, J. (1998). Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol. Cell Biol. 18, 4272-4281.
123. Selemon, L. D., and Goldman-Rakic, P. S. (1999). The reduced neuropil hypothesis: A circuit based model of schizophrenia. Biol. Psychiat. 45, 17-25.
124. Selinfreud, R. H., Barger, S. W., Pledger, W. J., and Van Eldik, L. J. (1991). Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc. Natl. Acad. Sci. USA 88, 3554-3558.
125. Sharma, T., and Antonova, L. (2003). Cognitive function in schizophrenia: Deficits, functional consequences, and future treatment. Psychiat. Clin. North Am. 26, 25-40.
126. Sheng, J. G., Mrak, R. E., Bales, K. R., Cordell, B., Paul, S. M., Jones, R. A., Woodward, S., Zheu, Y. Q., McGinnes, J. M., and Griffin, W. S. T. (2000). Overexpression of the neuritotrophic cytokine S100β precedes the appearance of neuritic β-amyloid plaques in APPV717F mice. J. Neurochem. 74, 295-301.
127. Shenton, M. E., Dickey, C. C., Frumin, M., and McCarley, R. W. (2001). A review of MRI findings in schizophrenia. Schizophr. Res. 49, 1-52.
128. Sheu, F. S., Azmitia, E. C., Marshak, D. R., Paker, P. J., and Routtenberg, A. (1994). Glial-derived S100b protein selectively inhibits recombinant β protein kinase C (PKC) phosphorylation of neuron-specific protein F1/GAP41. Mol. Brain Res. 21, 62-66.
129. Sheu, F. S., Huang, F. L., and Huang, K. P. (1995). Differential responses of protein kinase C substrates (MARCKS, neuromodulin, and neurogranin) phosphorylation to calmodulin and S100. Arch. Biochem. Biophys. 16, 335-342.
130. Skripnikova, E. V., and Gusev, N. B. (1989). Interaction of smooth muscle caldesmon with S-100 protein. FEBS Lett. 257, 380-382.
131. Smith, S. P., Barber, K. R., Dunn, S. D., and Shaw, G. S. (1998). Structural influence of cation binding to recombinant human brain S100b: Evidence for calcium-induced exposure of a hydrophobic surface. Biochemistry 35, 8805-8814.
132. Sorci, G., Agneletti, A. L., Bianchi, R., and Donata, R. (1998). Association of S100B with intermediate filaments and microtubules in glial cells. Biochim. Biophys. Acta 1448, 277-289.
133. Stefansson, H., Sarginson, J., Kong, A., Yates, P., Steinthorsdottir, V., Gudfinnsson, E., Gunnarsdottir, S., Walker, N., Petursson, H., Crombie, C., Ingason, A., Gulcher, J. R., Stefansson, K., and St. Clair, D. (2003). Association of neuregulin I with schizophrenia confirmed in a Scottish population. Am. J. Hum. Genet. 72, 83-87.
134. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., Chou, T. T., Hjaltason, O., Birgisdottir, B., Jonsson, H., Gudnadottir, V. G., Gudmunsdottir, E., Bjornson, A., Invarsson, B., Ingason, A., Sigfusson, S., Hardardottir, H., Harvey, R. P., Lai, D., Zhou, M., Brunner, D., Mutel, V., Gonzalo, A., Lemke, G., Sainz, J., Johannesson, G., Andresson, T., Gudbjartsson, D., Manolescu, A., Frigge, M. L., Gurney, M. E., Kong, A., Gulcher, J. R., Petursson, H., and Stefansson, K. (2002). Neuregulin I and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892.
135. Swanson, L. W., Teyler, T. J., and Thompson, R. F. (1982). Hippocampal long-term potentiation: Mechanisms and implications for memory. Neurosci. Res. Progr. Bull. 20, 613-769.
136. Ueda, S., Gu, X. F., Whitaker-Azmitia, P. M., Naruse, I., and Azmitia, E. C. (1994a). Neuro-glial neurotrophic interaction in the S-100β retarded mutant mouse (Polydactyly nagoya). I. Immunocytochemical and neurochemical studies. Brain Res. 633, 275-283.
137. Ueda, S., Hou, X. P., Whitaker-Azmitia, P. M., and Azmitia, E. C. (1994b). Neuroglial neurotrophic interaction in the S-100β retardet mutant mouse (Polydactyly nagoya). II. Co-cultures study. Brain Res. 633, 284-288.
138. Ueda, S., Kokotos Leonardi, E. T., Bell, J., II, and Azmitia, E. C. (1995). Serotonergic sprouting into transplanted C-6 gliomas is blocked by S-100β antisense gene. Mol. Brain. Res. 29, 365-368.
139. Van Eldik, L. J., Christie-Pope, B., Bolin, L. M., Shooter, E. M., and Whetseel, W. O., Jr. (1991). Neurotrophic activity of S-100β in cultures of dorsal root ganglia from embryonic chick and fetal rat. Brain Res. 542, 280-285.
140. Vives, V., Alonso, G., Solal, A. C., Joubert, D., and Legraverend, C. (2003). Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice. J. Comp. Neurol. 457, 404-419.
141. Wang, S., Rosengren, L. E., Franlund, M., Hamberger, A., and Haglid, K. G. (1999). Bcl-2 expression regulates cell sensitivity to S100β-mediated apoptosis. Mol. Brain Res. 70, 167-176.
142. Whitaker-Azmitia, P. M., Borella, A., and Raio, N. (1995). Serotonin depletion in the adult rat causes loss of the dentritic marker MAP-2: A new animal model of schizophrenia? Neuropsychopharmacology 12, 269-272.
143. 1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res. 528, 155-159.
144. Whitaker-Azmitia, P. M., Wingate, M., Borella, A., Gerlai, R., Roder, J., and Azmitia, E. C. (1997). Transgenic mice overexpressing the neurotrophic factor S-100β show neuronal cytoskeletal and behavioral signs of altered aging processes: Implications for Alzheimer's disease and Down's syndrome. Brain Res. 776, 51-60.
145. Wiesmann, M., Wandinger, K. P., Missler, U., Eckhoff, D., Rothermundt, M., Arolt, V., and Kirchner, H. (1999). Elevated plasma levels of S-100b protein in schizophrenic patients. Biol. Psychiat. 45, 1508-1511.
146. 2+-dependent manner. Protein Sci. 7, 794-798.
147. Wills, F. L., McCubbin, W. D., and Kay, C. M. (1993). Characterization of the smooth muscle calponin and calmodulin complex. Biochemistry 32, 2321-2328.
148. 1a-receptors: Evidence for a glial mechanism. Brain Res. 782, 235-239.
149. Winningham-Major, F., Staecker, J. L., Barger, S. W., Coats, S., and Van Eldik, L. J. (1989). Neurite expension and neuronal survival activities of recombinant S100β proteins that differ in the content and position of cysteine residues. J. Cell Biol. 109, 3063-3071.
150. Winocur, G., Roder, J., and Lobaugh, N. (2001). Learning and memory in S100-β transgenic mice: An analysis of impaired and preserved function. Neurobiol. Learn. Mem. 75, 230-243.
151. Woods, B. T. (1998). Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism Am. J. Psychiat. 155, 1661-1670.
152. Xiong, Z., O'Hanlon, D., Becker, L. E., Roder, J., MacDonald, J. F., and Marks, A. (2000). Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice. Exp. Cell Res. 257, 281-289.
153. Yao, J., Kitt, C., and Reeves, R. H. (1995). Chronic elevation of S100β protein does not alter APP mRNA expression of promote β-amyloid deposition in the brains of aging transgenic mice. Brain Res. 702, 32-36.
154. Ziegler, D. R., Innocente, C. E., Leal, R. B., Rodnight, R., and Goncalves, C. A. (1998). The S100B protein inhibits phosphorylation of GFAP and vimentin in a cytoskeletal fraction from immature rat hippocampus. Neurochem. Res. 23, 1259-1263.
155. Zimmer, D. B., and Van Eldik, L. J. (1986). Identification of a molecular target for the calcium-modulated protein S100: Fructose-1,6-bisphosphate aldolase. J. Biol. Chem. 261, 11424-11428.
156. Zimmer, D. B., Cornwall, E. H., Landar, A., and Song, W. (1995). The S100 protein family: History, function, and expression. Brain Res. Bull. 37, 417-429.